Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...

Chinese soda maker Dayao is gearing up for a Hong Kong initial public offering as early as the second half of 2025, people ...

Chinese banks have been pitching to work on the blockbuster Hong Kong secondary listing of the world’s leading EV battery maker CATL for as little as 0.01 per cent in fees, highlighting cut-throat ...

Finding the Right Venue for Your Event in Hong Kong When it comes to hosting an event, the venue you select can make all the ...

More jumbo stock offerings from some of China's biggest onshore-listed companies are making their way to Hong Kong, supported by demand from global funds, improved valuations and market reforms, ...

Chinese HR service provider 51job is set to go public in Hong Kong after its privatization in 2022, according to Chinese ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the ...

CHINESE soda maker Dayao is gearing up for a Hong Kong initial public offering (IPO) as early as the second half of 2025, ...

The Inner Mongolia-based maker of carbonated beverages, juices and protein drinks is working with advisers on the size and ...